CPC A61L 31/16 (2013.01) [A61K 31/337 (2013.01); A61K 31/353 (2013.01); A61K 31/436 (2013.01); A61K 31/58 (2013.01); A61L 27/34 (2013.01); A61L 27/44 (2013.01); A61L 27/54 (2013.01); A61L 29/08 (2013.01); A61L 29/085 (2013.01); A61L 29/16 (2013.01); A61L 31/08 (2013.01); A61L 31/10 (2013.01); A61M 25/09 (2013.01); A61M 25/10 (2013.01); A61L 2300/416 (2013.01); A61L 2300/426 (2013.01); A61L 2300/602 (2013.01); A61L 2300/606 (2013.01); A61L 2300/61 (2013.01); A61L 2420/06 (2013.01); A61M 2025/105 (2013.01); H05K 999/99 (2013.01)] | 20 Claims |
1. A composition comprising:
a therapeutic preparation comprising a gallate containing compound and a water-insoluble therapeutic agent at least partly dissolved in a solid phase of the gallate containing compound, where the gallate containing compound is present in an amount by weight equal to or greater than the amount by weight of the water-insoluble therapeutic agent.
|